Ultrasound biomicroscopy is the most successful in measuring sulcus diameter


Ciliary sulcus-to-sulcus (STS) diameter is most accurately measured using ultrasound biomicroscopy (UBM).

Ciliary sulcus-to-sulcus (STS) diameter is most accurately measured using ultrasound biomicroscopy (UBM), according to a paper published in the Journal of Cataract and Refractive Surgery.

The study, led by Dr Julia Biermann, University Eye Hospital Freiberg im Breisgau, Germany, measured the STS diameter at 0, 45, 90 and 135 degrees using 35 MHz UBM. The Orbscan scanning-slit topography and the partial coherence interferometry (PCI) biometry (IOLMaster) were used to obtain the 0-degree automated horizontal white-to-white (WTW) diameter.

The 90˚ STS and the 0˚ STS were compared using the paired t test and the Pearson correlation was used to determine whether the 0˚ STS diameter could be predicted from the 0˚ WTW diameter.

In emmetropic and myopic eyes the mean SE refraction was −0.48 D ± 0.35 SD and −9.55 ± 3.70 D, respectively.

The 90˚ STS was greater than 0˚ STS in 35 of the 37 eyes studied. The mean 90˚ STS and 0˚ STS were 12.51 ± 0.43 mm and 12.19 ± 0.47 mm, respectively. The mean scanning-slit topography of 0˚ WTW diameters were 11.73 ± 0.37 mm and for the PCI biometry they were 12.20 ± 0.42 mm.

A strong correlation was found between 0˚ STS and 0˚ WTW with PCI biometry and scanning-slit topography in emmetropic eyes. However, the correlation was weaker in myopic eyes.

Overall, UBM is the most accurate way to measure sulcus diameter measurements. The study also suggests that WTW diameter is not suitable for determining a posterior chamber phakic intraocular lens (PC pIOL) diameter- especially in myopic eyes.

Recent Videos
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
Paulo Antonio Silva, Associate Professor of Ophthalmology at Harvard Medical School
Intraocular Pressure Outcomes Following Suprachoroidal Triamcinolone Acetonide in Patients With Glaucoma, Ocular Hypertension, or Steroid Response
Durga Borkar, MD, MMCi, discusses FAS inhibition with ONL-1204
Theodore Leng, MD, MS, speaks about 12-Month Real-World Clinical and Anatomical Outcomes With Faricimab in Patients With Diabetic Macular Edema:The FARETINA-DME Study
Rishi P. Singh, MD, discussed his presentation on the results from part 1 of the Phase 2/3 SIGLEC trial assessing AVD-104 for GA
Carl C. Awh, MD, FASRS, speaks with Hattie Hayes of Ophthalmology Times Europe
© 2024 MJH Life Sciences

All rights reserved.